Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-267-7 | CAS number: 3794-83-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 487 (in vitro Mammalian Cell Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Etidronic acid
- EC Number:
- 220-552-8
- EC Name:
- Etidronic acid
- Cas Number:
- 2809-21-4
- Molecular formula:
- C2H8O7P2
- Test material form:
- not specified
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- EXPERIMENT I
- without S9 mix: 13.7, 24.1, 42.1, 73.7, 128.9, 225.7, 394.9, 691.1, 1209.4, 2116.4 µg/mL
- with S9 mix: 13.7, 24.1, 42.1, 73.7, 128.9, 225.7, 394.9, 691.1, 1209.4, 2116.4 µg/mL
EXPERIMENT II
- without S9 mix: 13.7, 24.1, 42.1, 73.7, 128.9, 225.7, 394.9, 691.1, 1209.4, 2116.4 µg/mL - Vehicle / solvent:
- Deionised water
Controlsopen allclose all
- Untreated negative controls:
- other: solvent control served as negative control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without S9 - pulse treatment
- Untreated negative controls:
- other: solvent control served as negative control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: demecolcin
- Remarks:
- without S9 - continuous treatment
- Untreated negative controls:
- other: solvent control served as negative control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9
- Details on test system and experimental conditions:
- HUMAN LYMPHOCYTES
Blood samples were drawn from healthy non-smoking donors not receiving medication. For this study, blood was collected from a male donor (29 years old) for Experiment I and from a male donor (31 years old) for Experiment II. The lymphocytes of the respective donors have been shown to respond well to stimulation of proliferation with PHA and to positive control substances. All donors had a previously established low incidence of micronuclei in their peripheral blood lymphocytes.
Human lymphocytes were stimulated for proliferation by the addition of the mitogen PHA to the culture medium for a period of 48 hours. The cell harvest time point was approximately 2 – 2.5 x AGT (average generation time). Any specific cell cycle time delay induced by the test item was not accounted for directly.
CULTURE CONDITIONS
Blood cultures were established by preparing an 11 % mixture of whole blood in medium within 30 hrs after blood collection. The culture medium was Dulbecco's Modified Eagles Medium/Ham's F12 (DMEM/F12, mixture 1:1) already supplemented with 200 mM GlutaMAX™. Additionally, the medium was supplemented with penicillin/streptomycin (100 U/mL/100 μg/mL), the mitogen PHA (3 μg/mL), 10 % FBS (fetal bovine serum), 10 mM HEPES and the anticoagulant heparin (125 U.S.P.-U/mL). All incubations were done at 37 °C with 5.5 % CO2 in humidified air. - Evaluation criteria:
- Evaluation of the slides was performed using NIKON microscopes with 40 x objectives. The micronuclei were counted in cells showing a clearly visible cytoplasm area. The criteria for the evaluation of micronuclei are described in the publication of Countryman and Heddle. The micronuclei have to be stained in the same way as the main nucleus. The area of the micronucleus should not extend the third part of the area of the main nucleus. At least 1000 binucleate cells per culturewere scored for cytogenetic damage on coded slides. The frequency of micronucleated cells was reported as % micronucleated cells. To describe a cytotoxic effect the CBPI is determined in approximately 500 cells per culture and cytotoxicity is described as % cytostasis. A CBPI of 1 (all cells are mononucleate) is equivalent to 100 % cytostasis.
CBPI=(MONCx1)+(BINCx2)+(MUNCx3)/n
CBPI Cytokinesis-block proliferation index
n Total number of cells
MONC Mononucleate cells
BINC Binucleate cells
MUNC Multinucleate cells
Cytostasis % = 100 – 100 [(CBPIT – 1) / (CBPIC – 1)]
T Test item
C Solvent control - Statistics:
- Statistical significance will be confirmed by using the Chi-squared test (α < 0.05) using the validated R Script CHI2.Rnw for those values that indicate an increase in the number of cells with micronuclei compared to the concurrent solvent control.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
Any other information on results incl. tables
In both experiments no precipitation of the test item in the culture medium was observed.
No relevant influence on osmolarity was observed. The pH was adjusted to physiological values.
In Experiment I in the absence and presence of S9 mix and in Experiment II in the absence of S9 mix, no cytotoxicity was observed up to the highest applied concentration.
No relevant increase in micronucleated cells was observed after treatment with the test item. However, in Experiment I in the presence of S9 mix, at a concentration of 691.1 μg/mL a statistically significant increase in the number of micronucleated cells (0.75 %) was observed after treatment with the test item. The value lies within the range of the laboratory historical control data (0.15 – 1.70 % micronucleated cells) and can be estimated as biologically irrelevant.
In both experiments, either Demecolcin (100.0 ng/mL), MMC (2.0 μg/mL) or CPA (17.5 μg/mL) were used as positive controls and showed distinct increases in cells with micronuclei.
Experiment | Exposure | Conc. [µg/mL] | CBPI | Cytostasis [%] | Micronucleated cells [%] |
I | 4 h -S9 | SC | 1.88 | 0.30 | |
I | 4 h -S9 | PC | 1.14 | 84.7 | 10.30 |
I | 4 h -S9 | 691.1 | 1.67 | 24.4 | 0.10 |
I | 4 h -S9 | 1209.4 | 1.79 | 10.0 | 0.50 |
I | 4 h -S9 | 2116.4 | 1.75 | 14.7 | 0.35 |
II | 20 h -S9 | SC | 1.51 | 1.35 | |
II | 20 h -S9 | PC | 1.44 | 12.5 | 5.45 |
II | 20 h -S9 | 394.9 | 1.79 | nc | 0.55 |
II | 20 h -S9 | 691.1 | 1.60 | nc | 0.60 |
II | 20 h -S9 | 1209.4 | 1.53 | nc | 0.20 |
I | 4 h +S9 | SC | 1.92 | 0.30 | |
I | 4 h +S9 | PC | 1.46 | 50.3 | 4.85 |
I | 4 h +S9 | 691.1 | 1.95 | nc | 0.75 |
I | 4 h +S9 | 1209.4 | 1.91 | 1.2 | 0.70 |
I | 4 h +S9 | 2116.4 | 1.91 | 0.7 | 0.30 |
SC = Solvent control
PC = Positive control
CBPI = Proliferation index
nc = not calculated (CBPI equal or higher than solvent control value)
Applicant's summary and conclusion
- Conclusions:
- In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes. Therefore, SAT 140001 is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to the highest required or evaluable concentrations.
- Executive summary:
The test item SAT 140001, dissolved in deionised water, was assessed for its potential to induce micronuclei in human lymphocytes in vitro in two independent experiments. The following study design was performed:
Without S9
With S9
Exp. I
Exp. II
Exp. I
Stimulation period
48 h
48 h
48 h
Exposure period
4 h
20 h
4 h
Recovery
16 h
-
16 h
Cytochalasin B exposure
20 h
20 h
20 h
Total culture period
88 h
88 h
88 h
In each experimental group two parallel cultures were analysed. Per culture 1000 binucleated cells were evaluated for cytogenetic damage.
The highest applied concentration in this study (2116.4 μg/mL of the test item) was chosen with regard to the purity (94.5%) of the test item and with respect to the current OECD Guideline 487. Dose selection of the cytogenetic experiment was performed considering the toxicity data in accordance with OECD Guideline 487.
In Experiment I in the absence and presence of S9 mix and in Experiment II in the absence of S9 mix, no cytotoxicity was observed up to the highest applied concentration.
No relevant increase in micronucleated cells was observed after treatment with the test item. However, in Experiment I in the presence of S9 mix, at a concentration of 691.1 μg/mL a statistically significant increase in the number of micronucleated cells (0.75 %) was observed after treatment with the test item. The value lies within the range of the laboratory historical control data (0.15 – 1.70 % micronucleated cells) and can be estimated as biologically irrelevant.
Appropriate mutagens were used as positive controls. They induced statistically significant increases in cells with micronuclei.
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes. Therefore, SAT 140001 is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to the highest required or evaluable concentrations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)